Use of Human Intravenous Immunoglobulin in Veterinary Clinical Practice.

[1]  S. Vassileva,et al.  Erythema Multiforme, Stevens–Johnson Syndrome, and Toxic Epidermal Necrolysis , 2019, Atlas of Dermatology, Dermatopathology and Venereology.

[2]  N. Ishimaru,et al.  Dual Role of Fas/FasL-Mediated Signal in Peripheral Immune Tolerance , 2017, Front. Immunol..

[3]  B. Gelfand,et al.  Intravenous immune globulin suppresses angiogenesis in mice and humans , 2016, Signal Transduction and Targeted Therapy.

[4]  E. R. Stiehm,et al.  Adverse effects of human immunoglobulin therapy. , 2013, Transfusion medicine reviews.

[5]  S. Sum,et al.  A prospective randomized clinical trial of vincristine versus human intravenous immunoglobulin for acute adjunctive management of presumptive primary immune-mediated thrombocytopenia in dogs. , 2013, Journal of veterinary internal medicine.

[6]  M. Ballow.  The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders. , 2011, The Journal of allergy and clinical immunology.

[7]  J. Callum,et al.  Use of intravenous immune globulin in the ICU: a retrospective review of prescribing practices and patient outcomes , 2010, Transfusion medicine.

[8]  M. Scott,et al.  Prothrombotic and inflammatory effects of intravenous administration of human immunoglobulin G in dogs. , 2009, Journal of veterinary internal medicine.

[9]  P. J. Armstrong,et al.  A prospective, randomized, double-blinded, placebo-controlled study of human intravenous immunoglobulin for the acute management of presumptive primary immune-mediated thrombocytopenia in dogs. , 2009, Journal of veterinary internal medicine.

[10]  Megan F. Whelan,et al.  Use of mycophenolate mofetil as a rescue agent in the treatment of severe generalized myasthenia gravis in three dogs. , 2009, Journal of veterinary emergency and critical care.

[11]  R. Hardy,et al.  Treatment of Evans' syndrome with human intravenous immunoglobulin and leflunomide in a diabetic dog. , 2009, Journal of the American Animal Hospital Association.

[12]  Megan F. Whelan,et al.  Use of human immunoglobulin in addition to glucocorticoids for the initial treatment of dogs with immune-mediated hemolytic anemia. , 2009, Journal of veterinary emergency and critical care.

[13]  J. Kirmse.  The Nurse's Role in Administration of Intravenous Immunoglobulin Therapy , 2009, Home healthcare nurse.

[14]  S. Grozdanic,et al.  Antibody-mediated retinopathies in canine patients: mechanism, diagnosis, and treatment modalities. , 2008, The Veterinary clinics of North America. Small animal practice.

[15]  P. J. Armstrong,et al.  Treatment of severe immune-mediated thrombocytopenia with human IV immunoglobulin in 5 dogs. , 2007, Journal of veterinary internal medicine.

[16]  L. Zinman,et al.  IV immunoglobulin in patients with myasthenia gravis , 2007, Neurology.

[17]  J. Keating,et al.  The use of intravenous human immunoglobulin in treatment of severe pemphigus foliaceus in a dog. , 2006, Journal of veterinary internal medicine.

[18]  L. Cavacini,et al.  Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin. , 2006, The New England journal of medicine.

[19]  U. Giger,et al.  Treatment of severe adverse cutaneous drug reactions with human intravenous immunoglobulin in two dogs. , 2006, Journal of the American Animal Hospital Association.

[20]  O. Abdel-Wahab,et al.  Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature , 2006, Transfusion.

[21]  D. Ward,et al.  Evaluation of canine serum for the presence of antiretinal autoantibodies in sudden acquired retinal degeneration syndrome. , 2006, Veterinary ophthalmology.

[22]  Y. Shoenfeld,et al.  Intravenous immunoglobulin , 2005, Clinical reviews in allergy & immunology.

[23]  Elyse Murphy,et al.  Developing Practice Guidelines for the Administration of Intravenous Immunoglobulin , 2005, Journal of infusion nursing : the official publication of the Infusion Nurses Society.

[24]  R. Lemieux,et al.  Therapeutic intravenous immunoglobulins. , 2005, Molecular immunology.

[25]  T. Nuttall,et al.  Successful intravenous human immunoglobulin treatment of drug-induced Stevens-Johnson syndrome in a dog. , 2004, The Journal of small animal practice.

[26]  M. Sato,et al.  IgG Anti-IgA Subclasses in Common Variable Immunodeficiency and Association with Severe Adverse Reactions to Intravenous Immunoglobulin Therapy , 2004, Journal of Clinical Immunology.

[27]  M. Kruskall,et al.  Intravenous immune globulins: an update for clinicians , 2003, Transfusion.

[28]  S. Kaveri,et al.  Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases. , 2003, Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology.

[29]  R. S. Padilla,et al.  Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases. , 2003, Archives of dermatology.

[30]  M. Hässig,et al.  Anwendung von humanem Immunglobulin bei Hunden mit primärer immunbedingter hämolytischer Anämie , 2002 .

[31]  F. Chiarini,et al.  The role of intravenous immunoglobulin therapy in autoimmune and inflammatory disorders , 2002, Neurological Sciences.

[32]  U. Giger,et al.  Comparison of platelet count recovery with use of vincristine and prednisone or prednisone alone for treatment for severe immune-mediated thrombocytopenia in dogs. , 2002, Journal of the American Veterinary Medical Association.

[33]  U. Giger,et al.  Use of human immunoglobulin for treatment of severe erythema multiforme in a cat. , 2002, Journal of the American Veterinary Medical Association.

[34]  S. Kaveri,et al.  Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. , 2001, The New England journal of medicine.

[35]  M. Stella,et al.  Toxic Epidermal Necrolysis Treated with Intravenous High-Dose Immunoglobulins: Our Experience , 2001, Dermatology.

[36]  T. Ratko,et al.  A Multicenter Drug Use Surveillance of Intravenous Immunoglobulin Utilization in US Academic Health Centers , 2000, The Annals of pharmacotherapy.

[37]  M. Sturzenegger,et al.  Adverse Effects of Intravenous Immunoglobulin Therapy , 1999, Drug safety.

[38]  J. Guy,et al.  Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases. , 1999, Archives of ophthalmology.

[39]  L. Glickman,et al.  Effects of human intravenous immunoglobulin on canine monocytes and lymphocytes. , 1998, American journal of veterinary research.

[40]  S. Whittaker,et al.  Dermatological uses of high-dose intravenous immunoglobulin. , 1998, Archives of dermatology.

[41]  D. Bruyette,et al.  Intravenous human immunoglobulin for the treatment of immune-mediated hemolytic anemia in 13 dogs. , 1997, Journal of veterinary internal medicine.

[42]  M. Perazella,et al.  Renal insufficiency after intravenous immune globulin therapy: a report of two cases and an analysis of the literature. , 1997, Journal of the American Society of Nephrology : JASN.

[43]  J. C. Scott-Moncrieff,et al.  Human intravenous immunoglobulin therapy. , 1997, Seminars in veterinary medicine and surgery.

[44]  P. Snyder,et al.  Intravenous administration of human immune globulin in dogs with immune-mediated hemolytic anemia. , 1997, Journal of the American Veterinary Medical Association.

[45]  J. C. Scott-Moncrieff,et al.  Treatment of nonregenerative anemia with human gamma-globulin in dogs. , 1995, Journal of the American Veterinary Medical Association.

[46]  M. Dalakas,et al.  Aseptic Meningitis Associated with High-Dose Intravenous Immunoglobulin Therapy: Frequency and Risk Factors , 1994, Annals of Internal Medicine.

[47]  C. Duhem,et al.  Side-effects of intravenous immune globulins. , 1994, Clinical and experimental immunology.

[48]  C. Murphy,et al.  Anti-retinal immunoglobulins in canine ocular diseases. , 1988, Seminars in veterinary medicine and surgery.

[49]  M. emoranda.  Appropriate uses of human immunoglobulin in clinical practice: memorandum from an IUIS/WHO meeting. , 1982, Bulletin of the World Health Organization.